Aging Arteries May Fuel Heart Disease Beyond Cholesterol

Cholesterol is a major cause of artery disease, but it does not explain every cardiovascular event in older adults. This review examines how aging within artery walls may amplify damage from circulating fats. Its central argument is that aging cells, persistent inflammation, and changes in gene regulation reinforce one another, helping plaques develop and potentially become more dangerous.

The authors synthesized literature published from 2020 onward alongside foundational studies, rather than conducting a new experiment. They describe how stressed cells lining arteries and forming vessel walls can stop dividing and release inflammatory signals. Aging immune cells and expanding blood cell clones may further sustain inflammation, while high blood sugar can leave lasting inflammatory programming.

The review also links disrupted gene regulation to vascular aging, including reduced activity of protective sirtuin proteins and altered chemical marks on RNA. It discusses connections with biological age measurements such as GrimAge, without establishing their clinical usefulness here. The authors emphasize differences between women and men and suggest that midlife metabolic problems and hormonal shifts influence how artery disease evolves.

Potential treatments include approaches that quiet inflammatory signals from senescent cells and others that remove those cells. Metformin and natural plant compounds are discussed as candidates, not proven cardiovascular treatments for aging arteries. Experimental delivery systems, including nanoparticles designed to generate targeted immune cells inside the body, offer early laboratory evidence that selective removal might reduce unwanted effects elsewhere in tissues.

For current care, these ideas complement rather than replace established cholesterol management and other cardiovascular risk reduction. The abstract provides no pooled effect estimates, detailed study selection methods, or evidence that these experimental strategies prevent heart attacks in humans. This summary is based on the abstract only; animal findings and mechanistic arguments should not be mistaken for demonstrated clinical benefit or established treatment safety.